High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.3M
$1,324,574
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
Discretionary Sell
2026-03-09
$87,074
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
Discretionary Sell
|
2026-03-09 | $87,074 | S | Form 4 |
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
10b5-1 SellΔOwn -24.4%
2025-12-19
$251,100
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
10b5-1 SellΔOwn -24.4%
|
2025-12-19 | $251,100 | S | Form 4 |
|
SUPN
M
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
Other
2025-12-19
$379,500
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
Other
|
2025-12-19 | $379,500 | M | Form 4 |
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
10b5-1 SellΔOwn -49.2%
2025-12-19
$757,050
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
10b5-1 SellΔOwn -49.2%
|
2025-12-19 | $757,050 | S | Form 4 |
|
SUPN
M
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
Other
2025-12-19
$197,000
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
Other
|
2025-12-19 | $197,000 | M | Form 4 |
|
SUPN
M
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
Equity Compensation
2025-12-19
$0
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
Equity Compensation
|
2025-12-19 | $0 | M | Form 4 |
|
SUPN
M
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
Equity Compensation
2025-12-19
$0
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
Equity Compensation
|
2025-12-19 | $0 | M | Form 4 |
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
Discretionary SellΔOwn -24.4%
2025-09-12
$229,350
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
Discretionary SellΔOwn -24.4%
|
2025-09-12 | $229,350 | S | Form 4 |
|
SUPN
M
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
Other
2025-09-12
$197,000
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
Other
|
2025-09-12 | $197,000 | M | Form 4 |